HVAX Technologies Limited (NSE SME)

User profile picture

HVAX Technologies Limited (NSE SME)

September 27, 2024 – October 1, 2024

Price ₹435 - ₹458
Premium ₹25
Lot size 300
Allotment Oct 3, 2024
Listing Oct 7, 2024

Lead Manager(s)
Address
HVAX Technologies Limited
601, Lodha Supremus,
I-Think Techno Campus,
Kanjurmarg (East), Mumbai - 400042
Phone: 022 4972 5039
Email: compliance@hvax.in
Website: http://www.hvax.in/
Subscription

Last updated on 01-Oct-2024 18:31:02

CategoryOfferedAppliedTimes
QIB138000193440014.02
NIB105300824310078.28
RETAIL244500653370026.72
Total4878001671120034.26
Retail Apps21779© IPO Premium
HNI Interest Cost Per Share (7 Days)
@7%
₹48.13
@8%
₹55.01
@9%
₹61.88
@10%
₹68.76
@11%
₹75.63
@12%
₹82.51
About
Category Lot(s) Qty Amount Reserved
Retail 1 300 137400 815
HNI 2 600 274800 351
IPO Reservations
Investor CategoryShares OfferedNo. of Shares
Retail33.40%244500
NII (HNI)14.39%105300
Anchor28.47%207000
QIB18.85%138000
Market Maker5.08%37200
Total 100.00%732000
HVAX Technologies IPO Details
Issue Size732,000 shares
(aggregating up to ₹33.53 Cr)
Fresh Issue732,000 shares
(aggregating up to ₹33.53 Cr)
Issue TypeBook Built Issue IPO
Listing AtNSE SME
Share holding pre issue2,044,875
Share holding post issue2,776,875
Market Maker portion37,200 shares
Aftertrade Broking
Key Performance Indicator
KPIMar-24Mar-23Mar-22
ROE39.29%35.63%42.18%
ROCE25.17%22.20%26.91%
RONW30.69%30.24%34.83%
D/E0.800.980.84
EPS
(Diluted)
47.3628.1222.59
P/E
Pre IPO
9.97
P/E
Post IPO
13.54
Company Financials
HVAX Technologies Limited Financial Information (Restated)

HVAX Technologies Limited's revenue increased by 12% and profit after tax (PAT) rose by 80% between the financial year ending with March 31, 2024 and March 31, 2023.

PeriodMar 2024Mar 2023Mar 2022
Assets6,366.327,825.595,386.78
Revenue10,746.999,613.866,879.13
Profit939.07520.37418.15
Net Worth3,059.831,720.771,200.4
Reserves2,991.671,659.081,138.71
Borrowing2,437.291,692.211,010.03
Amount in ₹ Lakhs
 
About Company

HVAX Technologies Limited, established in 2010, specializes in turnkey engineering, procurement, and execution services for controlled environment and cleanroom infrastructure, with a focus on the pharmaceutical and healthcare sectors. The company offers a range of third-party-manufactured products such as cleanroom wall and ceiling panels, covings, cleanroom doors, air handling units, BMS equipment, and utility distribution systems. Serving a diverse clientele across pharmaceuticals, healthcare, chemicals, and FMCG, HVAX has completed around 200 projects in India and 15 countries, including Algeria, the UAE, New Zealand, and Saudi Arabia. With strong fiscal performance, the company executed 52 projects generating ₹6,632.27 lakhs in FY 2022, 48 projects with ₹9,343.63 lakhs in FY 2023, and 53 projects yielding ₹8,445.73 lakhs in FY 2024. Employing 125 permanent staff and 21 temporary workers as of August 31, 2024, HVAX is poised for continued growth in the cleanroom infrastructure market.

Strength

Experienced Leadership: HVAX Technologies benefits from a seasoned management team with extensive expertise in turnkey engineering and cleanroom infrastructure, driving strong operational execution.

Comprehensive Execution: The company offers end-to-end services, from design and consulting to procurement and project execution, ensuring seamless project delivery for complex environments.

Strong Order Pipeline: With a robust order book and a history of successful projects in India and internationally, HVAX is well-positioned for continued growth and expansion.

Weakness

Customer Concentration: HVAX Technologies relies on a limited number of large customers, and losing any of them could negatively impact its revenue and profitability.

Supplier Dependence: The Company depends on a few key suppliers, and disruptions with any of these could affect its ability to maintain smooth business operations.

Related Party Transactions: A significant portion of HVAX's supplies come from related parties, such as HVAX Engineering and Isovax Technologies, which could present risks related to dependency and conflict of interest.